Ion Beam Applications SA
XBRU:IBAB

Watchlist Manager
Ion Beam Applications SA Logo
Ion Beam Applications SA
XBRU:IBAB
Watchlist
Price: 12 EUR 1.01% Market Closed
Market Cap: 363.4m EUR

Operating Margin
Ion Beam Applications SA

5.6%
Current
3%
Average
4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
5.6%
=
Operating Profit
28.1m
/
Revenue
498.2m

Operating Margin Across Competitors

Ion Beam Applications SA
Glance View

Market Cap
352.2m EUR
Industry
Health Care

Ion Beam Applications SA engages in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. The company is headquartered in Louvain-La-Neuve, Brabant-Wallon. IBA is also active in the sterilization and ionization field. The firm operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

IBAB Intrinsic Value
21.78 EUR
Undervaluation 45%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
5.6%
=
Operating Profit
28.1m
/
Revenue
498.2m
What is the Operating Margin of Ion Beam Applications SA?

Based on Ion Beam Applications SA's most recent financial statements, the company has Operating Margin of 5.6%.

Back to Top